GlassScriptPhysician profile
Soudabeh Ahadi
NPI 1174510275
$4,749.64
in general payments reported to CMS, 2019-2025
39 companies · $476 in 2025
The $476 reported for 2025 was more than what 79% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $915 · 2020: $413 · 2021: $839 · 2022: $817 · 2023: $633 · 2024: $655 · 2025: $476.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,703 · Education: $61.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,702.64 |
| Education | $61.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $566.99 | 2019-2025 | |
| Novo Nordisk INC | $498.43 | 2020-2025 | Wegovy |
| Astellas Pharma US INC | $472.30 | 2022-2025 | Veozah, Myrbetriq |
| Amgen INC. | $423.13 | 2019-2025 | Evenity, Prolia |
| Aspira Women'S Health INC | $333.14 | 2019-2022 | |
| Daiichi Sankyo INC. | $304.92 | 2019-2024 | Injectafer |
| Myovant Sciences INC. | $226.07 | 2021-2022 | |
| Allergan, INC. | $210.88 | 2019-2020 | |
| Pfizer INC. | $197.25 | 2019-2025 | |
| Therapeuticsmd, INC. | $181.36 | 2019-2022 | |
| Sage Therapeutics, LLC | $129.96 | 2024-2025 | Zurzuvae |
| Mayne Pharma Commercial LLC | $112.87 | 2023-2025 | |
| Shield Therapeutics INC | $99.74 | 2022-2025 | |
| Caldera Medical, INC | $81.23 | 2023 | Desara |
| Teva Pharmaceuticals USA, INC. | $76.74 | 2019 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $72.88 | 2021-2023 | Twirla |
| Radius Health, INC. | $59.64 | 2020-2024 | Tymlos |
| Coopersurgical, INC. | $57.58 | 2021-2024 | Paragard T 380a |
| Sumitomo Pharma America, INC. | $54.73 | 2025 | Myfembree, Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $54.72 | 2019-2023 | |
| Organon LLC | $43.17 | 2021-2024 | |
| Lilly USA, LLC | $42.87 | 2020-2025 | Zepbound |
| Mylan Pharmaceuticals INC. | $41.45 | 2019-2020 | |
| Hologic Sales and Service, LLC | $40.96 | 2019-2023 | Acessa Provu System |
| Currax Pharmaceuticals LLC | $38.89 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $37.01 | 2019 | |
| Minerva Surgical, INC | $35.86 | 2019 | |
| Millicent US INC | $35.46 | 2025 | Femlyv, Intrarosa, Femring |
| Boston Scientific Corporation | $31.29 | 2019-2020 | |
| Becton, Dickinson and Company | $30.83 | 2019-2023 | Bd Affirm Vpiii Microbial Identification Test |
| Ethicon US, LLC | $23.10 | 2025 | Vistaseal, Surgicel Nu-Knit, Stratafix |
| Smith+Nephew, INC. | $19.96 | 2024 | Pico |
| Alvogen INC | $19.04 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $18.50 | 2022 | |
| Axonics, INC. | $18.08 | 2023 | Axonics |
| Mimedx Group, INC. | $17.41 | 2024 | |
| Exeltis, USA INC. | $16.24 | 2021 | |
| Coloplast Corp | $12.76 | 2023 | Saffron |
| Lupin INC. | $12.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Soudabeh Ahadi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.